These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8634807)

  • 1. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions.
    Garcia A; Fulton JE
    Dermatol Surg; 1996 May; 22(5):443-7. PubMed ID: 8634807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid.
    Lim JT
    Dermatol Surg; 1999 Apr; 25(4):282-4. PubMed ID: 10417583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
    Guevara IL; Pandya AG
    Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study.
    Sarkar R; Kaur C; Bhalla M; Kanwar AJ
    Dermatol Surg; 2002 Sep; 28(9):828-32; discussion 832. PubMed ID: 12269877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability and efficacy of a novel formulation in the treatment of melasma.
    Guevara IL; Werlinger KD; Pandya AG
    J Drugs Dermatol; 2010 Mar; 9(3):215-8. PubMed ID: 20232581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma.
    Ibrahim ZA; Gheida SF; El Maghraby GM; Farag ZE
    J Cosmet Dermatol; 2015 Jun; 14(2):113-23. PubMed ID: 25847063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening.
    Draelos ZD; Yatskayer M; Bhushan P; Pillai S; Oresajo C
    Cutis; 2010 Sep; 86(3):153-8. PubMed ID: 21049734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma.
    Chaudhary S; Dayal S
    J Drugs Dermatol; 2013 Oct; 12(10):1149-53. PubMed ID: 24085051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of glycolic acid peels in the treatment of melasma.
    Hurley ME; Guevara IL; Gonzales RM; Pandya AG
    Arch Dermatol; 2002 Dec; 138(12):1578-82. PubMed ID: 12472345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolic acid peels in the treatment of melasma among Asian women.
    Lim JT; Tham SN
    Dermatol Surg; 1997 Mar; 23(3):177-9. PubMed ID: 9145959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different therapeutic modalities for treatment of melasma.
    Azzam OA; Leheta TM; Nagui NA; Shaarawy E; Hay RM; Hilal RF
    J Cosmet Dermatol; 2009 Dec; 8(4):275-81. PubMed ID: 19958431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels.
    Garg VK; Sarkar R; Agarwal R
    Dermatol Surg; 2008 Aug; 34(8):1032-9; discussion 1340. PubMed ID: 18430172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
    Rendon M; Cardona LM; Bussear EW; Benitez AL; Colón LE; Johnson LA
    Cutis; 2008 Nov; 82(5):372-8. PubMed ID: 19090343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of melasma: a review of clinical trials.
    Gupta AK; Gover MD; Nouri K; Taylor S
    J Am Acad Dermatol; 2006 Dec; 55(6):1048-65. PubMed ID: 17097400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of therapeutic effects of conventional and liposomal form of 4% topical hydroquinone in patients with melasma.
    Taghavi F; Banihashemi M; Zabolinejad N; Salehi M; Jaafari MR; Marhamati H; Golnouri F; Dorri M
    J Cosmet Dermatol; 2019 Jun; 18(3):870-873. PubMed ID: 30105847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and evaluation of pigment distribution and response to therapy in melasma using in vivo reflectance confocal microscopy: a preliminary study.
    Ardigo M; Cameli N; Berardesca E; Gonzalez S
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1296-303. PubMed ID: 20337829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial.
    Gheisari M; Dadkhahfar S; Olamaei E; Moghimi HR; Niknejad N; Najar Nobari N
    J Cosmet Dermatol; 2020 Jan; 19(1):167-172. PubMed ID: 31102345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma.
    Espinal-Perez LE; Moncada B; Castanedo-Cazares JP
    Int J Dermatol; 2004 Aug; 43(8):604-7. PubMed ID: 15304189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.